A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...] Read More »
Category: Providers
340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’
A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...] Read More »
New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...] Read More »
A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...] Read More »
Medicare administrative contractors (MACs) covering more than half the states have initiated lump sum repayments to 340B hospitals, after getting [...] Read More »
An influential senator’s inquiry into the nation’s two largest 340B pharmacy chains comes amid growing scrutiny into 340B contract pharmacies [...] Read More »
Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...] Read More »
Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...] Read More »
Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...] Read More »
The Health Resources and Services Administration (HRSA) has announced plans to host a webinar for federal grantees just days prior [...] Read More »